LI Jingnan. Gastrointestinal Mucosal Barrier and Standardization of the Application of Mucosal Protective Agents: Interpretation on the Consensus of Clinical Experts on Gastrointestinal Mucosal Protection(2021, Fuzhou)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 796-799. DOI: 10.12290/xhyxzz.2022-0256
Citation: LI Jingnan. Gastrointestinal Mucosal Barrier and Standardization of the Application of Mucosal Protective Agents: Interpretation on the Consensus of Clinical Experts on Gastrointestinal Mucosal Protection(2021, Fuzhou)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 796-799. DOI: 10.12290/xhyxzz.2022-0256

Gastrointestinal Mucosal Barrier and Standardization of the Application of Mucosal Protective Agents: Interpretation on the Consensus of Clinical Experts on Gastrointestinal Mucosal Protection(2021, Fuzhou)

More Information
  • Author Bio:

    LI Jingnan, E-mail: lijn2008@126.com

  • Received Date: May 05, 2022
  • Accepted Date: June 05, 2022
  • Available Online: June 09, 2022
  • Issue Publish Date: September 29, 2022
  • The gastrointestinal tract is the largest organ connecting the human body and the outside world. The gastrointestinal mucosa is not only an important barrier connecting the internal body and the outside world, but also plays a key role in maintaining normal functions of the gastrointestinal tract. The injuries of gastrointestinal mucosal barrier are the common pathogenesis mechanisms in the occurrence and development of gastrointestinal diseases. However, there is still a lack of deep and systematic understanding of gastrointestinal mucosa, especially small intestinal mucosa. In clinical practice, more attentions have been paid to the role of injury factors, but the importance of mucosal protection is ignored. In order to improve the understanding of gastrointestinal mucosa protection and standardize the clinical application of gastrointestinal mucosal protective agents, the Gastrointestinal Hormone and Mucosal Barrier Group, Chinese Society of Gastroenterology, Chinese Medical Association formulated the first expert consensus on gastrointestinal mucosal protection in China, which was offi- cially published at the end of 2021. This paper interprets the background, process and main content of this consensus, so as to raise awareness among medical staff, and standardize clinical diagnosis and treatment.
  • loading
  • [1]
    Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans[J]. Gut, 2019, 68: 1516-1526. DOI: 10.1136/gutjnl-2019-318427
    [2]
    中华医学会消化病学分会胃肠激素与黏膜屏障学组. 胃肠道黏膜保护临床专家共识(2021年, 福州)[J]. 中华消化杂志, 2021, 41: 798-811. DOI: 10.3760/cma.j.cn311367-20210930-00524
    [3]
    Yandrapu H, Sarosiek J. Protective Factors of the Gastric and Duodenal Mucosa: An Overview[J]. Curr Gastroenterol Rep, 2015, 17: 24. DOI: 10.1007/s11894-015-0452-2
    [4]
    Capaldo CT, Powell DN, Kalman D. Layered defense: how mucus and tight junctions seal the intestinal barrier[J]. J Mol Med (Berl), 2017, 95: 927-934. DOI: 10.1007/s00109-017-1557-x
    [5]
    Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners?[J]. Gut, 2020, 69: 2232-2243. DOI: 10.1136/gutjnl-2020-322260
    [6]
    Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans-Epithelial Permeability[J]. Int J Mol Sci, 2020, 21: 6402。 DOI: 10.3390/ijms21176402
    [7]
    Wirth HP, Yang M. Different Pathophysiology of Gastritis in East and West?A Western Perspective[J]. Inflamm Intest Dis, 2016, 1: 113-122. DOI: 10.1159/000446300
    [8]
    Guzmán-Mejía F, Godínez-Victoria M, Vega-Baurista A, et al. Intestinal Homeostasis under Stress Siege[J]. Int J Mol Sci, 2021, 22: 5095 DOI: 10.3390/ijms22105095
    [9]
    杨莹韵, 李渊, 张海芳, 等. 北京地区慢性非萎缩性胃炎伴糜烂患者277例的病因及治疗现状[J]. 中华消化杂志, 2021, 41: 27-32. DOI: 10.3760/cma.j.cn311367-20210718-00390
    [10]
    Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review[J]. J Gastroenterol, 2020, 55: 481-495. DOI: 10.1007/s00535-019-01657-8
    [11]
    Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemo-therapy-induced mucositis[J]. Cancer, 2003, 98: 1531-1539. DOI: 10.1002/cncr.11671
    [12]
    Chulkina M, Beswick EJ, Pinchuk IV. Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation[J]. Int J Mol Sci, 2020, 21: 9165. DOI: 10.3390/ijms21239165
    [13]
    Gyires K, Laszlo SB, Lazar B, et al. Similar and Distinct Mechanisms in the Protective Processes of Upper and Lower Gastrointestinal Tract[J]. Curr Pharm Des, 2018, 24: 1936-1946. DOI: 10.2174/1381612824666180516101531
    [14]
    Xiong L, Huang X, Li L, et al. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study[J]. Dig Liver Dis, 2015, 47: 280-284. DOI: 10.1016/j.dld.2015.01.005
    [15]
    Kuramoto T, Umegaki E, Nouda S, et al. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflam-matory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study[J]. BMC Gastroenterol, 2013, 13: 85.
    [16]
    韩涛涛, 陈楚岩, 王静, 等. 瑞巴派特对非甾体抗炎药相关小肠黏膜损伤的保护机制[J]. 中华消化杂志, 2021, 41: 183-189.
  • Related Articles

    [1]China Behavioral Medical Research Center for Growth and Development,Behavioral Medicine Branch of Chinese Medical Association, Committee on Growth,Development and Metabolism,China Maternal and Child Health Research Association, PAN Hui, BAN Bo. Consensus on the Establishment and Operational Standards of Standardized Growth-and-Development Medical Centers Based on Active Health Principles (2025)[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2025-0208
    [2]CHEN Miao, YANG Chen, LIU Ziwei, CAO Wei, ZHANG Bo, LIU Xin, LI Jingnan, LIU Wei, PAN Jie, WANG Jian, ZHENG Yuehong, CHEN Yuexin, LI Fangda, DU Shunda, NING Cong, CHEN Limeng, YUE Cai, NI Jun, PENG Min, GUO Xiaoxiao, WANG Tao, LI Hongjun, LI Rongrong, WU Tong, HAN Bing, ZHANG Shuyang, Multidiscipline Collaboration Group on Rare Disease at Peking Union Medical College Hospital. Expert Consensus of Multidisciplinary Diagnosis and Treatment for Paroxysmal Nocturnal Hemoglobinuria(2024)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1011-1028. DOI: 10.12290/xhyxzz.2024-0416
    [3]CHAI Wenzhao, LIU Jingjing, WANG Xiaoting, MA Xiaojun, TANG Bo, ZHANG Qing, WANG Bin, WANG Xiaomeng, ZHU Shihong, CHEN Wenjin, CHEN Zujun, YANG Quanhui, YANG Rongli, DING Xin, ZHAO Hua, CHENG Wei, DUNA Jun, GAO Jingli, LIU Dawei. 2024 Expert Consensus on Hospital Acquired Infection Control Principles in the Department of Critical Care Medicine[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 522-531. DOI: 10.12290/xhyxzz.2024-0301
    [4]LIU Hui, YANG Nan, SHI Qianling, LUO Xufei, ZHANG Hairong, TIAN Jinhui, JIN Yinghui, CHEN Yaolong, Methodology and Technology Specialisation Committee of the STAR Working Group. Methodology of Scientific, Transparent and Applicable Rankings for Chinese Guidelines and Consensus Related Literature Published in the Medical Journals: ample Identification and Speciality Assignment[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 429-434. DOI: 10.12290/xhyxzz.2024-0112
    [5]YU Huan, WANG Xiaomei, WANG Rui, PENG Guoqing, GONG Liyun. Interpretation on the Consensus Recommendations of Enhanced Recovery for Liver Transplantation by the International Liver Transplantation Society[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 68-76. DOI: 10.12290/xhyxzz.2023-0357
    [6]YANG Xiaoxi, TIAN Xinping, LI Mengtao, LENG Xiaomei, ZHAO Yan, ZENG Xiaofeng. Interpretation on the Consensus on Targeted Drug Therapy for Spondyloarthritis[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 58-67. DOI: 10.12290/xhyxzz.2023-0391
    [7]Chinese Society of Rare Diseases, Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society. Expert Consensus for the Diagnosis and Treatment of Bartter Syndrome in China(2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 744-757. DOI: 10.12290/xhyxzz.2023-0207
    [8]Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
    [9]WANG Zi-jun, ZHOU Qi, XING Dan, YANG Nan, LUO Xu-fei, ZHANG Jing-yi, SHI Qian-ling, ZHAO Si-ya, LIU Hui, LIU Xiao, LI Qin-yuan, DU Liang, YANG Ke-hu, CHEN Yao-long. Reporting Quality of Literature Interpreting Clinical Practice Guidelines/Consensus: A Cross-sectional Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 260-267. DOI: 10.12290/xhyxzz.20200250
  • Cited by

    Periodical cited type(2)

    1. 吴雪彬,翁桂珍. 老年肿瘤化疗患者生前预嘱知信行的风险因素研究. 中国卫生标准管理. 2025(02): 191-194 .
    2. 陈龙,任明辉. 生前预嘱制度的检视与完善. 协和医学杂志. 2025(02): 523-528 . 本站查看

    Other cited types(1)

Catalog

    Article Metrics

    Article views (3945) PDF downloads (257) Cited by(3)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return